Ginkgo Bioworks Holdings Inc (NYSE: DNA) is -87.07% lower on its value in year-to-date trading and has touched a low of $5.26 and a high of $75.20 in the current 52-week trading range. The question becomes, what are the chances the stock will make a comeback and enjoy potential growth. Why not look at analysts view on what the future holds for the stock. The DNA stock was last observed hovering at around $8.79 in the last trading session, with the day’s loss setting it -0.05%.
Currently trading at $8.74, the stock is -6.36% and 3.04% above its SMA20 and SMA50 respectively. However, with a daily trading volume of 1.33 million and changing -0.57% at the moment leaves the stock -53.07% off its SMA200. DNA registered -87.79% loss for a year compared to 6-month loss of -48.52%. The firm has a 50-day simple moving average (SMA 50) of $8.4652 and a 200-day simple moving average (SMA200) of $18.82475.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The stock witnessed a 35.50% gain in the last 1 month and extending the period to 3 months gives it a 9.11%, and is -15.39% down over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 10.94% over the week and 10.07% over the month.
Ginkgo Bioworks Holdings Inc (DNA) has around 1218 employees, a market worth around $502.37M and $217.95M in sales. Profit margin for the company is -298.78%. Distance from 52-week low is 66.16% and -88.38% from its 52-week high. The company has generated returns on investments over the last 12 months (-52.37%).
with sales reaching $44.43M over the same period.The EPS is expected to grow by 45.22% this year, but quarterly earnings will post -9.45% year-over-year. Quarterly sales are estimated to grow 27.83% in year-over-year returns.
229.0 institutions hold shares in Ginkgo Bioworks Holdings Inc (DNA), with institutional investors hold 73.27% of the company’s shares. The shares outstanding are 41.37M, and float is at 36.49M with Short Float at 20.32%. Institutions hold 68.37% of the Float.
The top institutional shareholder in the company is VIKING GLOBAL INVESTORS LP with over 143.09 million shares valued at $47.83 million. The investor’s holdings represent 7.1383 of the DNA Shares outstanding. As of 2024-06-30, the second largest holder is VANGUARD GROUP INC with 138.96 million shares valued at $46.46 million to account for 6.9327 of the shares outstanding. The other top investors are BAILLIE GIFFORD & CO which holds 134.43 million shares representing 6.7063 and valued at over $44.94 million, while ANCHORAGE CAPITAL GROUP, L.L.C. holds 3.485 of the shares totaling 69.85 million with a market value of $23.35 million.
Ginkgo Bioworks Holdings Inc (DNA) Insider Activity
Still, SEC filings show that on Dec 17 ’24, Che Austin (Officer) Proposed Sale 99 shares at an average price of $9.32 for $923.0. The insider now directly holds shares of Ginkgo Bioworks Holdings Inc (DNA).
